Compare SOR & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOR | FBRX |
|---|---|---|
| Founded | 1968 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.9M | 367.4M |
| IPO Year | N/A | N/A |
| Metric | SOR | FBRX |
|---|---|---|
| Price | $47.92 | $34.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 16.2K | ★ 199.7K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | ★ 7.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 6.50 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.41 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.41 | $4.90 |
| 52 Week High | $42.75 | $35.46 |
| Indicator | SOR | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.92 | 67.86 |
| Support Level | $46.51 | $30.50 |
| Resistance Level | $48.45 | $33.58 |
| Average True Range (ATR) | 0.80 | 3.47 |
| MACD | 0.05 | 0.22 |
| Stochastic Oscillator | 90.00 | 95.99 |
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).